Cargando…
The mTOR/AP-1/VEGF signaling pathway regulates vascular endothelial cell growth
Vascular restenosis is a common adverse event following percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). The atypical Ser/Thr protein kinase mammalian target of rapamycin (mTOR) plays an important role in cell differentiation and apoptosis. Vascular restenosis cau...
Autores principales: | Wang, Shuo, Lu, Jiawei, You, Qingsheng, Huang, Hua, Chen, Yingying, Liu, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288184/ https://www.ncbi.nlm.nih.gov/pubmed/27458160 http://dx.doi.org/10.18632/oncotarget.10756 |
Ejemplares similares
-
mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012) -
VEGF-mTOR signaling links obesity and endometrial cancer
por: Sahoo, Subhransu S., et al.
Publicado: (2018) -
The Translational Regulation in mTOR Pathway
por: Yang, Miaomiao, et al.
Publicado: (2022) -
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020) -
Liraglutide Improves Endothelial Function via the mTOR Signaling Pathway
por: Wu, Han, et al.
Publicado: (2021)